Hagan, Norway

Terje Michaelsen


 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 108(Granted Patents)


Company Filing History:


Years Active: 1994-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Terje Michaelsen: Innovator in Antibody Development

Introduction

Terje Michaelsen is a notable inventor based in Hagan, Norway. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 3 patents to his name, Michaelsen's work has the potential to impact medical treatments significantly.

Latest Patents

Michaelsen's latest patents focus on antibodies against HPA-1a. The first patent provides an isolated antibody that specifically binds to HPA-1a. It also includes a nucleic acid molecule that encodes the antibody, along with compositions that comprise the antibody. Furthermore, the patent outlines a method for producing the antibody and various methods and uses that employ it. Therapeutic applications of this antibody include treatment or prophylaxis of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The second patent mirrors the first, emphasizing the importance of this isolated antibody in medical applications.

Career Highlights

Throughout his career, Michaelsen has worked with several companies, including Rallybio IPA, LLC and Dynal AS. His experience in these organizations has contributed to his expertise in antibody development and biotechnology.

Collaborations

Michaelsen has collaborated with notable individuals in his field, including Oistein Ihle and Tor Brynjar Stuge. These collaborations have likely enhanced his research and development efforts.

Conclusion

Terje Michaelsen is a prominent inventor whose work in antibody development has the potential to advance medical treatments. His contributions to the field are noteworthy, and his patents reflect his innovative spirit.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…